BioSpace News Archive

Business

Pfizer, Valneva Lyme Vaccine Shows Promise in Pediatric Patients

Pfizer and its partner, Valneva, have announced positive Phase II data from its trial of vaccine candidate VLA15 in a pediatric population. VLA15 is intended to prevent Lyme Disease (LD).

April 26, 2022
·
2 min read
·
Hayley Shasteen
Study: Inhibiting ATX Improves Ability to Recover from Stroke

A new approach to improving a patient’s ability to recover from a stroke is discussed in an article published this month in Science Translational Medicine.

April 26, 2022
·
2 min read
·
Jazmine Colatriano
Drug Development

Concerns Resolved, FDA Clears Way for Gamida Cell’s Lymphoma Trial

Gamida Cell reported that the FDA had lifted its clinical hold on its cryopreserved formulation of GDA-201. It expects to launch a Phase I/II drug trial for those indications this year.

April 26, 2022
·
3 min read
·
Mark Terry
Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market

Sunshine Biopharma, Inc. announced that it entered into a securities purchase agreement with certain institutional and accredited investors for aggregate gross proceeds of approximately $19.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company.

April 26, 2022
·
5 min read
Drug Development

Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate

Saint-Herblain and New York, April 26, 2022 – Valneva SE, a specialty vaccine company, and Pfizer Inc. reported positive Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15.

April 26, 2022
·
11 min read
Business

Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing

RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, announced the appointment, effective May 3, 2022, of Drew Cronin-Fine as Executive Director, Head of U.S. Marketing.

April 26, 2022
·
4 min read
Extraction Kits Market is Projected to Reach a Market Value of US$ 2.39 Billion By 2032 - Comprehensive Research Report By FMI

DUBAI, United Arab Emirates, As per Future Market Insights, the global extraction kits market was valued at over US$ 1.15 Bn in 2021 and is expected to exhibit growth at a CAGR of 7.0% over the forecast period.

April 26, 2022
·
5 min read
Minoxidil Market: Key Trends | Growth Dynamics | Competitive Assessment - Global Industry Analysis [2020-2030]

Minoxidil, a prescription drug, is promoted as a topical formulation for promoting hair growth. The piperidino-pyrimidine derivative has 2,6-diamino-4-piperidinopyrimidine-1-oxide.

April 26, 2022
·
5 min read
Active Pharmaceutical Ingredients Market to reach US$ 331.3 Bn by 2031, Rise in incidence of chronic disease across the globe to drive the market

According to the report, the global active pharmaceutical ingredients market was valued at US$ 168 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031.

April 26, 2022
·
10 min read
Healthcare Additive Manufacturing Market: Insights Factors Drivers | Restraints | Challenges | Upcoming Opportunities [2020-2030]

The rapidly advancing medical setup and facilities, coupled with the rising demand for customized medical products stands as a key factor boosting the global healthcare additive manufacturing market during the forecast period, 2020 to 2030.

April 26, 2022
·
6 min read